The addition of a pregnenolone pendant group enhances the anticancer properties of titanocene dichloride in a mcf-7 xenograft model.

Ramos G, Loperena Y, Ortiz G, Reyes F, Szeto A, Vera J, Velez J, Morales J, Morrero D, Castillo L, Dharmawardhane S, Melendez E, Washington AV. The addition of a pregnenolone pendant group enhances the anticancer properties of titanocene dichloride in a mcf-7 xenograft model. Anticancer Res. 2014 Apr; 34(4):1609-15.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Cell Line, Tumor
Cell Proliferation
Drug Synergism
Female
Humans
Kidney
Liver
Mice
Organometallic Compounds
Pregnenolone
Tumor Burden
Xenograft Model Antitumor Assays

authors with profiles

Suranganie Dharmawardhane
Linette Castillo Pichardo

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support